Skip to main content

Table 1 Study sample demographic characteristics

From: Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy

  Study sample, n = 91 n (%) Non-responders, n = 41 n (%)
Male 73 (82) 36 (86)
Insurance   
Medicaid 52 (57) 27 (66)
Uninsured 23 (25) 8 (20)
Medicare 10 (11) 0 (0)
Private 9 (10) 6 (15)
Race/Ethnicity   
Caucasian 38 (42) 12 (29)
African-American 34 (37) 17 (42)
Hispanic 18 (20) 12 (29)
Asian 1 (1) 0 (0)
Buprenorphine treatment history   
Median buprenorphine dose, (range) 20 mg/day (1.5, 24) 16 mg/day (1, 24)
Mean time in treatment (months), (range) 28 (1, 71) 32 (1, 75)